Welcome to the American Journal of Clinical and Experimental Immunology, a premier publication dedicated to advancing the fields of clinical and experimental immunology. Published by E-CENTURY PUBLISHING CORP, this journal provides a platform for groundbreaking research, case studies, and comprehensive reviews that contribute to our understanding of the immune system and its implications for health and disease. With a focus on disseminating innovative findings and enhancing the dialogue among researchers, practitioners, and students, the journal aims to bridge the gap between laboratory discoveries and clinical applications. Although specific metrics such as the impact factor and Scopus ranks are currently not provided, the journal is committed to maintaining high standards of scholarly publishing and fostering open access to vital research. Located in Madison, WI, and available online via its E-ISSN 2164-7712, this journal is a valuable resource for those wishing to explore the intricacies of immunological research and its applications in clinical practice.

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

Immunopathologia Persa, published by NIKAN RESEARCH INST, is a premier open-access journal specializing in the fields of immunology, hematology, and endocrinology. Since its inception in 2015, the journal has aimed to disseminate high-quality research and innovative insights critical to understanding immune responses, disease mechanisms, and therapeutic strategies. Based in Iran, the journal contributes significantly to the academic landscape, with quarterly categorizations placing it in the fourth quartile across multiple vital sectors including Endocrinology, Diabetes and Metabolism, and Immunology. It features a diverse range of articles and studies that cater to both emerging and established researchers, aiding in the advancement of knowledge and clinical practice in immunopathology. With its commitment to open access, Immunopathologia Persa ensures that cutting-edge research is readily available to all, fostering a collaborative research environment and promoting the dissemination of findings globally. Researchers, professionals, and students are encouraged to explore the contents of this journal to stay abreast of the latest developments in these critical areas of health science.

Acta Dermatovenerologica Alpina Pannonica et Adriatica, published by the Dermatovenereological Society of Slovenia, stands as an important peer-reviewed journal in the fields of dermatology, infectious diseases, and general medicine. Established in 1994, this journal has built a solid reputation over the years, achieving a Q3 ranking in 2023 within its respective categories, which highlights its contribution and relevance in the academic community. With an ISSN of 1318-4458 and E-ISSN of 1581-2979, it aims to disseminate new research findings, review articles, and case reports that impact clinical practice and promote knowledge in dermatovenereology throughout the Alpine and Adriatic regions. Located in Ljubljana, Slovenia, the journal actively supports open access to its publications, ensuring that valuable insights are available to a global audience, which is crucial for advancing medical research and practice. The dedication to quality and scientific rigor makes Acta Dermatovenerologica Alpina Pannonica et Adriatica a must-read for researchers, practitioners, and students aiming to stay informed on the latest advancements in dermatology and related disciplines.

Rheumatology & Autoimmunity, published by WILEY, is an emerging academic journal that delves into the intricacies of rheumatological diseases and autoimmune disorders, providing a critical platform for researchers and practitioners within the field. With an ISSN of 2767-1410 and E-ISSN 2767-1429, the journal aims to disseminate cutting-edge research in both clinical and laboratory settings, enhancing knowledge and understanding among professionals and scholars. Although currently classified in Q4 for Immunology and Allergy, and Q3 for Internal Medicine and Rheumatology as of 2023, the journal is positioned for growth and greater visibility in the scientific community. The three-year publishing span from 2021 to 2024 signifies a commitment to addressing contemporary issues and fostering collaboration among various disciplines related to immunology. As an open access journal, it provides wide accessibility, ensuring that groundbreaking research is available to a broad audience. This journal is poised to become a vital resource for those dedicated to advancing the understanding and treatment of autoimmune conditions.

AUTOIMMUNITY, published by Taylor & Francis Ltd, is an influential journal dedicated to advancing the understanding of autoimmune diseases through rigorous research and scholarly discourse. With an ISSN of 0891-6934 and an E-ISSN of 1607-842X, this journal serves as a key resource for immunologists, medical professionals, and students engaged in investigating the complex mechanisms underpinning autoimmunity. Operating from the United Kingdom, it offers valuable insights into immunological and allergic phenomena, achieving respectable Scopus rankings in both Immunology and Allergy (106/233, Q3) and Immunology and Microbiology (125/236, Q2). Covering a broad spectrum of topics since its inception in 1988, AUTOIMMUNITY encourages the dissemination of innovative research findings and aims to enhance collaborative efforts within the field. While it currently adopts a conventional access model, the journal's commitment to quality and excellence positions it as a vital platform for those looking to engage with cutting-edge research in immunology.

Immunity, Inflammation and Disease is a premier open-access journal published by WILEY, dedicated to advancing the field of immunology and allergy. Launched in 2013, this journal has established itself as a significant platform for researchers and professionals to disseminate high-quality research findings and innovative insights that address critical issues in immune responses and inflammatory diseases. With an impact factor that reflects its growing influence and a current ranking in Q3 for Immunology and Q2 for Immunology and Allergy, this journal serves a diverse audience keen on exploring cutting-edge developments. Researchers are encouraged to submit their work to share their findings with a global reach, foster collaboration, and enhance the understanding of immune mechanisms and therapeutic strategies. Accessible since its inception, Immunity, Inflammation and Disease is committed to open science, ensuring that vital research is freely available for the advancement of knowledge within the academic community and beyond.

Case Reports in Immunology, published by HINDAWI LTD, is an esteemed open-access journal that has been contributing to the field of immunology since its launch in 2011. With both ISSN 2090-6609 and E-ISSN 2090-6617, the journal provides a platform for researchers to publish detailed case reports that explore diverse immunological conditions and novel treatment approaches. This journal is crucial for clinicians, researchers, and students alike, seeking to broaden their understanding of immunology's practical applications and advances. As of 2023, it holds a Q3 ranking in Immunology and Q2 in Immunology and Allergy, reflecting its growing relevance and contribution to the field. Additionally, it is indexed in Scopus, where it ranks #178 in Immunology and Allergy and #192 in Immunology and Microbiology, enhancing its visibility and impact. With a comprehensive accessibility model, the journal is dedicated to disseminating knowledge widely and enriching discussions in immunological research.

ImmunoTargets and Therapy is a leading open access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of immunology and its various therapeutic applications. Since its inception in 2012, the journal has rapidly become a vital resource for researchers, professionals, and students, achieving notable recognition with a Q1 ranking in both Immunology and Immunology and Allergy categories as of 2023. With an impressive Scopus ranking of #22 out of 233 in Medicine - Immunology and Allergy, and #25 out of 236 in Immunology and Microbiology, this journal maintains a 90th percentile standing in its field. ImmunoTargets and Therapy not only publishes original research articles, reviews, and clinical studies, but also fosters an inclusive platform for the dissemination of innovative findings critical to the fight against immunological disorders. Based in New Zealand, it serves a global audience, promoting knowledge exchange and collaboration through its open access model.